Glaxosmithkline Consumer Healthcare: Group Members

You are on page 1of 19

GROUP MEMBERS

GLAXOSMITHKLINE
1. Sana Saeed (0068)
CONSUMER 2. Asma Faizan (0073)
3. Hira Mansoor (0067)
HEALTHCARE 4. Bilal Afzal (0082)
5. Uzair Ali (0056)
6. Mohammad Shehryar (0020)
COMPANY FACTS
ACCOUNTING ANALYSIS

Inventory Costing Method -


Assets- Valued at Historical Cost FIFO (GSK & Abbot), Weighted
Average (AGP)

Revenue Recognition – Revenue Depreciation - Straight-line Method


recorded when earned

Intangible Assets - Annual Impairment


Investments - Recorded at Fair Value Assessment
Of Goodwill
LIQUIDITY & EFFICIENCY
LIQUIDITY & EFFICIENCY
MARKET RATIOS
MARKET RATIOS

Dividend Yield Ratio


Price Earning Ratio 1.96
35.00
1.94
30.00
25.00 1.92
20.00
15.00 1.90
10.00
5.00 1.88
-
2018 2019 2020 1.86

1.84
2018 2019 2020
PROFITABILITY RATIO
PROFITABILITY RATIO

Return on Equity (%) Net Profit Margin Ratio (%)


29.00
9.00
28.00 8.00
27.00 7.00
6.00
26.00 5.00
25.00 4.00
3.00
24.00 2.00
23.00 1.00
-
22.00
GSK GSK GSK
2018 2019 2020

Earnings Per Share


11.00
Gross Profit Margin Ratio (%)
10.50
31.00
30.00 10.00
29.00
28.00 9.50
27.00
26.00 9.00
25.00 8.50
24.00
GSK GSK GSK 8.00
2018 2019 2020
SOLVENCY RATIO
COMMON-SIZE FINANCIAL
STATEMENTS
COMMON-SIZE FINANCIAL
STATEMENTS
COMMON-SIZE FINANCIAL
STATEMENTS
COMMON-SIZE FINANCIAL
STATEMENTS
HORIZONTAL ANALYSIS
HORIZONTAL ANALYSIS
HORIZONTAL ANALYSIS
PROSPECTIVE OUTLOOK
Income
Statement         

  2018 2019 2020 2021 (P)


Net Sales              14,875                 16,317                 19,846     22,227.52
  10% 22% 10% 12%
Gross Profit                  4,404                   4,986                   5,328       6,606.72
                  29.61                   30.56 27% 24%
Operating Profit                  1,688                   1,892                   1,832       1,948.52
                    7.22                       7.71                       6.36 6.36%
Profit Before Tax                  1,463                   1,700                   1,774       1,898.18
  16% 4%   7%
Taxation                    (388)                       (442)                     (512)           550.47
         
Profit After
Taxation                  1,075                   1,258                   1,262       1,347.71
PROSPECTIVE OUTLOOK
Balance Sheet         

  2018 2019 2020 2021 (P)


Non Current Assets 2,788,202,890 3,059,655,473 3,638,317,010 4038531881

Percentage Growth  10% 19% 11%


Current Assets  5,166,053,806 5,922,968,338 7,335,653,671 8362645185
Percentage Growth    15% 24% 14%
Total Assets  7,954,256,696 8,982,623,811 10,973,970,681 12401177066
Percentage Growth         
Non Current Liabilities  127,340,706 186,629,828 239,753,880 294897272.4
Percentage Growth    47% 28% 23%
Current Liabilities 3,991,930,853 4,295,390,048 5,570,288,322 6238722921
Percentage Growth    8% 30% 12%
Total Liabilities  4,119,271,559 4,482,019,876 5,810,042,202 6533620193

You might also like